Ultragenyx Pharmaceutical

10 open jobs
10 open jobsSee all Companies

General information

Ultragenyx Pharmaceutical is a pharmaceutical company based in Novato, United States. It makes treatments for rare diseases, including three FDA-approved drugs: Mepsevii (vestronidase alfa), Crysvita (burosumab), and Dojolvi (triheptanoin).

Emil Kakkis founded the company in 2010 in Novato, California. It went public in 2014, raising $126 million in its IPO, and now trades on Nasdaq under the ticker RARE. It acquired Dimension Therapeutics in 2017 for gene therapy technology and GeneTx Biotherapeutics in 2022 for $75 million upfront. In 2020, it had 893 employees and revenue of $271 million. That matters: acquisitions gave Ultragenyx gene-therapy technology it didn't build in-house, backing its shift into rare-disease treatments beyond its first drugs.

Currently, there's a total of 22 job openings at Ultragenyx Pharmaceutical. Over the last 30 days, 20 jobs were added and 26 were removed (job postings usually stay up ~14 days before being removed). Ultragenyx Pharmaceutical is a top-tier H-1B sponsor.1

Headquarters
Novato, United States
Industry
Healthcare & Life Sci
Category
Pharma & Biotech
Visa sponsor
Yes

Hiring activity

10Open jobs
+15Added in 30 days
−41Closed in 30 days
18 daysHow long jobs stay open

New jobs added per week2

View these weekly figures as a table
Week beginningNew listings
July 20, 20269
July 27, 202610
August 3, 20269
August 10, 20261
August 17, 20265
August 24, 20265
August 31, 20264
September 7, 2026 (in progress)1

Open jobs

10 open · updated today

Page 1 of 1, most recently added first · Download (CSV)3

Want to know which of these 10 jobs are worth your time? Upload your CV and we'll score how well you match each one before you apply. It's free.

Score your CV for free before you apply

Visa sponsorship

Does Ultragenyx Pharmaceutical sponsor visas? Using USCIS data, we've collected the number of H-1Bs granted from 2021 to 2023 as well as the number of petitions they've requested so far this year. Ultragenyx Pharmaceutical is a top employer for applicants who require sponsorship. Currently, they have 5 jobs certified for sponsorship in 2026, at a median pay of $145,029.4

Visa petitions approved each year (USCIS)4

H1B petitions approved, by fiscal year (USCIS)
Fiscal yearApproved
FY202114
FY202216
FY20234

Based on public USCIS and Department of Labor records. Past filings do not guarantee future sponsorship. Browse all H1B sponsors →

Similar companies

Browse all companies hiring now →

Common questions

Is Ultragenyx Pharmaceutical hiring now?

Yes. There are 10 open jobs, with 15 added in the last 30 days. They close fast though, often within 18 days, so don't wait.

Does Ultragenyx Pharmaceutical sponsor H-1B visas?

Yes. Government records show 5 jobs certified for FY2026, at a median pay of $145,029.

Interview OS

Company pages built from daily checks of real hiring systems.

Create free account

Notes & sources

162 daily listing observations, Jun 7 to Sep 12 windowRechecked daily, last September 12, 2026
  1. 1. Company description. Written by InterviewOS from Ultragenyx Pharmaceutical's public materials and press coverage; facts are checked against the sources below.
  2. 2. Weekly counts. A count is the number of listings the pipeline saw for the first time in that week. Weeks begin Monday; the onboarding week is excluded from the scale and every average.
  3. 3. Live counts. Deduplicated live listings observed daily on Ultragenyx Pharmaceutical's own hiring system; last check September 12, 2026. Stale and syndicated posts on aggregator sites are not counted.
  4. 4. Federal visa records. USCIS H1B Employer Data Hub and US Department of Labor LCA disclosure files, matched to this company by name.

Sources
ultragenyx.com, checked daily
USCIS H-1B Employer Data Hub
US Department of Labor LCA disclosure files
About the data
Report a data issue with this page